Chemobrain: Is It Time to Initiate Guidelines for Assessment and Management?
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Works matching IS 08909091 AND DT 2014 AND VI 28 AND IP 9
Results: 23
1
2
Cancer- and Treatment-Related Cognitive Changes: What Can We Do Now? What Lies Ahead?
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
3
Cancer Treatment and Cognitive Function: Chemotherapy Is Not the Only Culprit.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
4
Neuroendocrine Tumors: Answers--and Questions.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
5
Tumor Heterogeneity: The Lernaean Hydra of Oncology?
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
6
Tumor Heterogeneity Is Fundamental to the Tumor Ecosystem.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
7
Tumor Heterogeneity and Implications for Clinical Practice.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
8
Best of the Blogs.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. C3
- By:
- Publication type:
- Article
9
Consultations in Ethics.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 811
- By:
- Publication type:
- Article
10
Chemobrain: Is It Time to Initiate Guidelines for Assessment and Management?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 809
- By:
- Publication type:
- Article
11
Cancer- and Treatment-Related Cognitive Changes: What Can We Do Now? What Lies Ahead?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 806
- By:
- Publication type:
- Article
12
Cancer Treatment and Cognitive Function: Chemotherapy Is Not the Only Culprit.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 804
- By:
- Publication type:
- Article
13
An Overview of Chemotherapy-Related Cognitive Dysfunction, or 'Chemobrain'.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 797
- By:
- Publication type:
- Article
14
What Next? Choosing Second-Line Therapy in Progressive Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 794, doi. 10.46883/onc.2014.2809.0794
- By:
- Publication type:
- Article
15
Routine Use of Maintenance Therapy in Follicular Lymphoma: Examine the Rationale for Maintenance Use Before Uniformly Adopting a Strategy.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 787
- By:
- Publication type:
- Article
16
Routine Use of Maintenance Therapy in Follicular Lymphoma: The Strategy Is Effective, Raising the Question, 'What Is the Most Important Measure of Success in the Current Era?'.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 786
- By:
- Publication type:
- Article
17
Tumor Heterogeneity: The Lernaean Hydra of Oncology?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 781
- By:
- Publication type:
- Article
18
Tumor Heterogeneity Is Fundamental to the Tumor Ecosystem.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 780
- By:
- Publication type:
- Article
19
Heterogeneity and Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 772
- By:
- Publication type:
- Article
20
Management of the Patient With Postpartum Breast Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 768
- By:
- Publication type:
- Article
21
Neuroendocrine Tumors: Answers--and Questions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 758
- By:
- Publication type:
- Article
22
An Update on Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 749
- By:
- Publication type:
- Article
23
Tumor Heterogeneity and Implications for Clinical Practice.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 726
- By:
- Publication type:
- Article